|
AstraZeneca highlights continued progress of oncology pipeline at ASCO 2016
|
20 May 2016 |
|
Selumetinib granted Orphan Drug Designation in the US for adjuvant treatment of differentiated thyroid cancer
|
12 May 2016 |
|
AstraZeneca completes acquisition of Takeda's respiratory business
|
09 May 2016 |
|
AstraZeneca launches integrated genomics approach to transform drug discovery and development
|
22 April 2016 |
|
AstraZeneca and Eli Lilly and Company announce continuation of pivotal clinical trial for people with early Alzheimer's disease
|
08 April 2016 |
|
Pandemic influenza vaccine receives positive CHMP opinion
|
01 April 2016 |
|
Brilinta preferred over clopidogrel in updated American College of Cardiology and American Heart Association guideline in acute coronary syndrome
|
31 March 2016 |
|
AstraZeneca reports top-line results from the Brilinta SOCRATES trial in stroke
|
23 March 2016 |
|
AstraZeneca's potential medicine for neuromyelitis optica receives FDA Orphan Drug Designation
|
09 March 2016 |
|
AstraZeneca enters licensing agreement with China Medical System Holdings for hypertension medicine
|
29 February 2016 |